CheckMate 274 is a phase III, randomized, double-blind trial of adjuvant nivolumab versus placebo for muscle-invasive urothelial carcinoma (MIUC) at high risk of recurrence after radical resection.

A rumor circulating in Hong Kong that a huge earthquake and tsunami will hit Japan this summer led to such a sharp drop in flight bookings that one airline was forced to reduce its services to ...

This is an updated version of a story first published on March 30, 2025. The original video can be viewed here. This past winter, a series of wildfires fueled by strong winds destroyed more than ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Wirecutter Staff No matter how long you’ve used an iPhone, there are ...

With a comprehensive business analytics tool, your company can analyze historical and real-time data, trends, and patterns to inform decisions that affect your organization positively. Reveal hidden ...